9 Meters Biopharma, Inc. (NMTRQ)
The Sandman Season 2: Netflix’s Epic Conclusion Begins July 2025
Penumbra Inc (PEN)
New THRIVE Data Demonstrates Penumbra’s CAVT™ Technology Is Associated with Reduced Related Readmissions and Complication Rates When Managing ALI
ResMed Inc (RMD)
ResMed Inc. Daily Stock Update
Summit Plc (SMMT)
Summit Plc - Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ORIC Pharmaceuticals Inc (ORIC)
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Fulcrum Therapeutics (FULC)
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Incyte Corporation (INCY)
Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
89bio Inc (ETNB)
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
TELA Bio Inc. (TELA)
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PolyPid (PYPD)
PolyPid to Host Conference Call and Webcast to Discuss D-PLEX₁₀₀ SHIELD II Phase 3 Trial Topline Results on Monday, June 9, 2025